Mendota Financial Group, LLC Neurocrine Biosciences Inc Transaction History
Mendota Financial Group, LLC
- $171 Billion
- Q1 2024
A detailed history of Mendota Financial Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mendota Financial Group, LLC holds 750 shares of NBIX stock, worth $103,117. This represents 0.06% of its overall portfolio holdings.
Number of Shares
750
Previous 1,127
33.45%
Holding current value
$103,117
Previous $148 Million
30.34%
% of portfolio
0.06%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
628Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.37 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$549 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$316 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$310 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...